Last update:

Oncology & Cancer news

Oncology & Cancer

Study identifies genetic factors crucial in acute myeloid leukemia survival for Black patients

Researchers have led a global study that identified molecular predictors of survival among Black patients with acute myeloid leukemia (AML). The study suggests a need to modify current AML risk layers by including ancestry-specific ...

Oncology & Cancer

Dual immunotherapy plus chemotherapy found to benefit specific subset of patients with lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor ...

Oncology & Cancer

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses ...

Oncology & Cancer

Long-term study shows early prostate cancer surgery extended life

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the ...

Oncology & Cancer

Study uncovers mutations and DNA structures driving bladder cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...

Oncology & Cancer

Do people with MS have an increased risk of cancer?

A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...

Oncology & Cancer

Blood test for brain cancer may be on horizon, research finds

Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College of Medicine have identified a biomarker that can be used in blood tests ...

Oncology & Cancer

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

In a recently published editorial in the journal Genes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hospital's Department of Hematology discussed aggressive type adult T-cell leukemia/lymphoma ...

Oncology & Cancer

Q&A: What is cholangiocarcinoma and how is it treated?

Question: My mother has been experiencing unusual and persistent fatigue, abdominal pain, and jaundice. After undergoing a CT scan, her doctor diagnosed her with cholangiocarcinoma. What is this type of cancer? And what treatment ...

Oncology & Cancer

Differences in animal biology can affect cancer drug development

A small but significant metabolic difference between human and mouse lung tumor cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new ...

Medications

New promising targeted drug for a rare leukemia

Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone. Venetoclax is a new targeted therapy option for the treatment of ...

Oncology & Cancer

Genes reveal kidney cancer's risk of recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

Medical research

Microcalcification 'fingerprints' can yield info about cancer

An interdisciplinary collaboration 10 years in the making used a materials science approach to "fingerprint" the calcium mineral deposits known as microcalcifications that reveal pathological clues to the progression of breast ...